Skip to content
AwardedSpainGoods

Radiofarmatseutikumi luteetsium (lu-177) – oksodotreotiid

Published
Published 20 January 2026

Overview

Hanke eesmärk on sõlmida raamleping radiofarmatseutikumi luteetsium (lu-177) – oksodotreotiid (edaspidi nimetatud ka kaup) ostmiseks koos transpordi korraldamisega. Raamleping sõlmitakse tähtajaga 24 kuud raamlepingu sõlmimisest arvates või kuni raamlepingu maksimaalse koguse 40 doosi täitumiseni sõltuvalt sellest, kumb asjaolu saabub varem. / Kõrvaldamise alused ja kvalifitseerimistingimused: Vaata hanke alusdokumentidest

Key details

Country
Spain
Status
Awarded
Category
Goods
Procedure
Direct
Published
20 January 2026
Classification (CPV)
Isotopic reagents

Award outcome

Awarded value
€614,012
Award date
16 January 2026
Winner
  • TAMRO EESTI OÜ

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    20 January 2026

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Radiofarmatseutikumi luteetsium (lu-177) – oksodotreotiid — won by TAMRO EESTI OÜ — Skim